Cargando…
Clinical Practice Guideline for Management of Primary Aldosteronism: What is New in the 2016 Update?
Primary Aldosteronism is the single most common cause of secondary hypertension and is associated with increased target organ injury. The Endocrine Society has recently released the updated Clinical Practice Guideline for Primary Aldosteronism entitled “The Management of Primary Aldosteronism: Case...
Autores principales: | Romero, Damian G, Yanes Cardozo, Licy L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5175479/ https://www.ncbi.nlm.nih.gov/pubmed/28018978 |
Ejemplares similares
-
Novel biomarkers of childhood and adolescent obesity
por: Yanes Cardozo, Licy L., et al.
Publicado: (2021) -
Obesity-associated cardiometabolic complications in polycystic ovary syndrome: The potential role of sodium-glucose cotransporter-2 inhibitors
por: Pruett, Jacob E., et al.
Publicado: (2023) -
Androgen Receptor Blocker Improves the Cardiometabolic Profile in a Rat Model of Polycystic Ovary Syndrome, but at What Cost?
por: Pruett, Jacob E, et al.
Publicado: (2021) -
Sodium-Glucose Cotransporter-2 Inhibition Benefits in Cardiorenal Risk in Men and Women
por: Pruett, Jacob E, et al.
Publicado: (2022) -
OR15-3 Contribution of Hyperandrogenemia to Dysbiosis, Gut Inflammation, and Dysregulation of Short-Chain Fatty Acid Homeostasis in Mouse Model of Polycystic Ovary Syndrome
por: Alsemeh, Amira, et al.
Publicado: (2022)